Таблица 3. Прогноз СБА в категории «Фармакологический эффект» для Финеренона при пороге Pa – Pi > 0.5. DB16165 – Финеренон; DBMET03393 и DBMET03398 – метаболиты финеренона.
Pa |
Pi |
Биологическая активность |
Идентификатор соединения |
Pa-Pi |
0.642 |
0.005 |
Myocardial infarction treatment |
DB16165 |
0.637 |
0.62 |
0.001 |
Antihyperaldosteronism |
DB16165 |
0.619 |
0.592 |
0.005 |
Heart failure treatment |
DB16165 |
0.587 |
0.581 |
0.004 |
Liver cirrhosis treatment |
DB16165 |
0.577 |
0.538 |
0.012 |
Cardiotonic |
DB16165 |
0.526 |
0.629 |
0.005 |
Myocardial infarction treatment |
DBMET03393 |
0.624 |
0.57 |
0.006 |
Heart failure treatment |
DBMET03393 |
0.564 |
0.559 |
0.004 |
Liver cirrhosis treatment |
DBMET03393 |
0.555 |
0.571 |
0.009 |
Urologic disorders treatment |
DBMET03394 |
0.562 |
0.595 |
0.005 |
Myocardial infarction treatment |
DBMET03398 |
0.59 |
0.556 |
0.007 |
Heart failure treatment |
DBMET03398 |
0.549 |
0.527 |
0.017 |
Antiischemic |
DBMET03398 |
0.51 |
0.522 |
0.019 |
Hepatic disorders treatment |
DBMET03398 |
0.503 |